Results 101 to 110 of about 28,018 (262)

Severe topiramate-associated hyperthermia resulting in persistent neurological dysfunction.

open access: yes, 2005
Topiramate has recently been reported to cause hyperthermia as a result of oligohydrosis, primarily in pediatric patients. All cases reported to date were clinically mild, without permanent systemic or neurologic dysfunction.
Lewis, Steven L, MD   +2 more
core   +1 more source

Reversible anorgasmia with topiramate therapy for migraine prophylaxis

open access: yes, 2010
Topiramate is an effective drug for the prevention of migraine headaches. On occasion, topiramate can be associated with a dose-related anorgasmia.
Kilbas, A.   +5 more
core   +1 more source

Preliminary evidence of long‐term safety and effectiveness of anti‐CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52‐week follow‐up retrospective study

open access: yesEpilepsia Open, EarlyView.
Abstract Migraine and epilepsy frequently coexist, but evidence on the safety of calcitonin gene‐related peptide (CGRP)‐targeting therapies in people with epilepsy is lacking. We evaluated long‐term migraine and epilepsy outcomes in a real‐world multicenter retrospective cohort of adults with comorbid migraine and epilepsy treated with anti‐CGRP ...
Marina Romozzi   +13 more
wiley   +1 more source

Topiramate use in alprazolam addiction

open access: yes, 2006
Alprazolam is successful in reducing anxiety but has a high addictive/misuse potential. Topiramate is a novel anticonvulsant which has been used as a mood stabilizer.
Douzenis, Athanasios   +4 more
core   +1 more source

Reversal of refractory epilepsy in an adult with GAMT deficiency: A case report and comparative literature review

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Guanidinoacetate methyltransferase (GAMT) deficiency is a rare autosomal recessive creatine biosynthesis disorder. Reports specifically focusing on adult patients remain scarce. Methods We report a 52‐year‐old female (the oldest documented case of GAMT deficiency to date) presenting with severe intellectual disability, refractory ...
Wei‐Hung Sung   +3 more
wiley   +1 more source

Secondary Bilateral Angle Closure Glaucoma due to Topiramate

open access: yesCase Reports in Ophthalmological Medicine, 2011
We examined a 39-year-old female with severe headache and blurred vision. She was on topiramate, 50 mg once a day for one week because of migraine.
Miguel Paciuc-Beja   +3 more
doaj   +1 more source

Bridging the Gap in Headache Care: Insights From the International Headache Society Survey in Nepal

open access: yesHealth Care Science, EarlyView.
Distinct relationships exist between urban and rural healthcare settings and key components of headache care in Nepal. Urban providers are more likely to be trained in migraine management, prescribe migraine‐specific medications, higher headache patient load and serve more specific adult group.
Rajeev Ojha   +13 more
wiley   +1 more source

The Influence of Topiramate on Morphine Dependence in Mice

open access: yesBiomolecules
Topiramate evokes pharmacological activity via a blockade of voltage-dependent sodium channels, reduction in glutamate release, inhibition of AMPA receptors and kainate receptors, and potentiation of GABAergic neurotransmission. Therefore, it is used not
Adrian Pysiewicz   +7 more
doaj   +1 more source

Research progress on the role of inflammatory mediators in the pathogenesis of epilepsy

open access: yesIbrain, Volume 11, Issue 1, Page 44-58, Spring 2025.
In the central nervous system, activated immune cells lead to the overproduction of inflammatory mediators through the corresponding signal pathway. Under the stimulation of inflammatory factors, neuroinflammation ultimately occurs. Overexpression of inflammatory mediators and activated immunocytes plays an important role in the emergence and ...
Yue Yu, Fei‐Ji Sun
wiley   +1 more source

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2014
Arianne N Sweeting,1 Eddy Tabet,1 Ian D Caterson,1,2 Tania P Markovic1,2 1Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; 2Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, University of Sydney ...
Sweeting AN   +3 more
doaj  

Home - About - Disclaimer - Privacy